A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 542-550

  Csóka, Balázs ^a   Németh, Zoltán H ^a,b   Rosenberger, Peter ^c   Eltzschig, Holger K ^d   Spolarics, Zoltán ^a   Pacher, Pál ^e   Selmeczy, Zsolt ^a   Koscsó, Balázs ^a   Himer, Leonóra ^a,f   Vizi, E Sylvester ^f   Blackburn, Michael R ^h   Deitch, Edwin A ^a   Haskó, György ^a,g  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^g UNIVERSITY OF DEBRECEN   (Hungary)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2B RECEPTOR; CHEMOKINE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; PHOSPHATASE; PROTEIN KINASE B; SYNAPTOPHYSIN; TENSIN; AUTACOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HEART; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; LIGATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUNCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPLEEN; ACUTE LUNG INJURY; ANIMAL; C57BL MOUSE; CECUM; DRUG ANTAGONISM; MALE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PERITONITIS; PHYSIOLOGY; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; CECUM; INFLAMMATION MEDIATORS; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONITIS; PUNCTURES; RECEPTOR, ADENOSINE A2B; SEPSIS; SURVIVAL RATE;

EID: 77956204462     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901295     Document Type: Article

References (40)

1. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554.
2. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96: 14541-14546.
3. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
4. Schmidt, H., W. G. Siems, T. Grune, and E. L. Grauel. 1995. Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus. J. Perinat. Med. 23: 167-174.
5. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53: 527-552.
6. Haskó, G., C. Szabó, Z. H. Németh, V. Kvetan, S. M. Pastores, and E. S. Vizi. 1996. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157: 4634-4640.
7. Haskó, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39.
8. Sitkovsky, M. V., D. Lukashev, S. Apasov, H. Kojima, M. Koshiba, C. Caldwell, A. Ohta, and M. Thiel. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22: 657-682.
9. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
10. Gallos, G., T. D. Ruyle, C. W. Emala, and H. T. Lee. 2005. A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis. Am. J. Physiol. Renal Physiol. 289: F369-F376.
11. Németh, Z. H., B. Csóka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Haskó. 2006. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J. Immunol. 176: 5616-5626.
12. Lee, H. T., M. Kim, J. D. Joo, G. Gallos, J. F. Chen, and C. W. Emala. 2006. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R959-R969.
13. Yang, D., Y. Zhang, H. G. Nguyen, M. Koupenova, A. K. Chauhan, M. Makitalo, M. R. Jones, C. St Hilaire, D. C. Seldin, P. Toselli, et al. 2006. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116: 1913-1923.
14. Yang, D., M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid. 2008. The A2b adenosine receptor protects against vascular injury. Proc. Natl. Acad. Sci. USA 105: 792-796.
15. Eckle, T., M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig. 2008. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035.
16. Eckle, T., A. Grenz, S. Laucher, and H. K. Eltzschig. 2008. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118: 3301-3315.
17. Kolachala, V. L., M. Vijay-Kumar, G. Dalmasso, D. Yang, J. Linden, L. Wang, A. Gewirtz, K. Ravid, D. Merlin, and S. V. Sitaraman. 2008. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 135: 861-870.
18. Csóka, B., Z. H. Németh, L. Virág, P. Gergely, S. J. Leibovich, P. Pacher, C. X. Sun, M. R. Blackburn, E. S. Vizi, E. A. Deitch, and G. Haskó. 2007. A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110: 2685-2695. (Pubitemid 47523193)
19. Németh, Z. H., D. Bleich, B. Csóka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabó, B. N. Cronstein, et al. 2007. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21: 2379-2388.
20. Eckle, T., T. Krahn, A. Grenz, D. Köhler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, and H. K. Eltzschig. 2007. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
21. Haudek, S. B., E. Spencer, D. D. Bryant, D. J. White, D. Maass, J. W. Horton, Z. J. Chen, and B. P. Giroir. 2001. Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 280: H962-H968.
22. Edwin, F., R. Singh, R. Endersby, S. J. Baker, and T. B. Patel. 2006. The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation. J. Biol. Chem. 281: 4816-4822.
23. Grenz, A., H. Osswald, T. Eckle, D. Yang, H. Zhang, Z. V. Tran, K. Klingel, K. Ravid, and H. K. Eltzschig. 2008. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5: e137.
24. Enoh, V. T., C. D. Fairchild, C. Y. Lin, T. K. Varma, and E. R. Sherwood. 2006. Differential effect of imipenem treatment on wild-type and NK cell-deficient CD8 knockout mice during acute intra-abdominal injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R685-R693.
25. Leibovici, L., M. Drucker, H. Konigsberger, Z. Samra, S. Harrari, S. Ashkenazi, and S. D. Pitlik. 1997. Septic shock in bacteremic patients: risk factors, features and prognosis. Scand. J. Infect. Dis. 29: 71-75.
26. Sun, C. X., H. Zhong, A. Mohsenin, E. Morschl, J. L. Chunn, J. G. Molina, L. Belardinelli, D. Zeng, and M. R. Blackburn. 2006. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116: 2173-2182.
27. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920. (Pubitemid 34024743)
28. Sitkovsky, M. V., and A. Ohta. 2005. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 26: 299-304.
29. Feoktistov, I., and I. Biaggioni. 1997. Adenosine A2B receptors. Pharmacol. Rev. 49: 381-402.
30. Böhrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Männel, B. W. Böttiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NFkappaB in the mortality of sepsis. J. Clin. Invest. 100: 972-985.
31. Paterson, R. L., H. F. Galley, J. K. Dhillon, and N. R. Webster. 2000. Increased nuclear factor kappa B activation in critically ill patients who die. Crit. Care Med. 28: 1047-1051.
32. Krishnagopalan, S., A. Kumar, J. E. Parrillo, and A. Kumar. 2002. Myocardial dysfunction in the patient with sepsis. Curr. Opin. Crit. Care 8: 376-388.
33. Kapadia, S., J. Lee, G. Torre-Amione, H. H. Birdsall, T. S. Ma, and D. L. Mann. 1995. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J. Clin. Invest. 96: 1042-1052.
34. Zhang, H., H. Y. Wang, R. Bassel-Duby, D. L. Maass, W. E. Johnston, J. W. Horton, and W. Tao. 2007. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am. J. Physiol. Heart Circ. Physiol. 292: H2408-H2416.
35. Yang, M., J. Wu, C. M. Martin, P. R. Kvietys, and T. Rui. 2008. Important role of p38 MAP kinase/NF-kappaB signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am. J. Physiol. Heart Circ. Physiol. 294: H994-H1001.
36. Peck-Palmer, O. M., J. Unsinger, K. C. Chang, J. S. McDonough, H. Perlman, J. E. McDunn, and R. S. Hotchkiss. 2009. Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages. Shock 31: 359-366.
37. Peck-Palmer, O. M., J. Unsinger, K. C. Chang, C. G. Davis, J. E. McDunn, and R. S. Hotchkiss. 2008. Deletion of MyD88 markedly attenuates sepsis-induced Tand B lymphocyte apoptosis butworsens survival. J. Leukoc. Biol. 83: 1009-1018.
38. Williams, D. L., C. Li, T. Ha, T. Ozment-Skelton, J. H. Kalbfleisch, J. Preiszner, L. Brooks, K. Breuel, and J. B. Schweitzer. 2004. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J. Immunol. 172: 449-456.
39. Schulte, G., and B. B. Fredholm. 2003. The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp. Cell Res. 290: 168-176.
40. Solenkova, N. V., V. Solodushko, M. V. Cohen, and J. M. Downey. 2006. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am. J. Physiol. Heart Circ. Physiol. 290: H441-H449.